VU6008667 is a selective negative allosteric modulator of the M5 muscarinic acetylcholine receptor subtype, with potential applications in central nervous system (CNS) research due to its high CNS penetrance; it exhibits a short half-life and moderate oral bioavailability in rats, making it suitable for in vivo pharmacokinetic studies.